KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Regeneron Pharmaceuticals (REGN) Other Non Operating Income (2016 - 2025)

Regeneron Pharmaceuticals has reported Other Non Operating Income over the past 12 years, most recently at $176.0 million for Q4 2025.

  • Quarterly results put Other Non Operating Income at $176.0 million for Q4 2025, up 914.81% from a year ago — trailing twelve months through Dec 2025 was $1.7 billion (up 100.92% YoY), and the annual figure for FY2025 was $1.7 billion, up 100.92%.
  • Other Non Operating Income for Q4 2025 was $176.0 million at Regeneron Pharmaceuticals, down from $755.8 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for REGN hit a ceiling of $755.8 million in Q3 2025 and a floor of -$183.8 million in Q1 2022.
  • Median Other Non Operating Income over the past 5 years was $165.4 million (2021), compared with a mean of $169.1 million.
  • Biggest five-year swings in Other Non Operating Income: tumbled 268.78% in 2021 and later soared 1937.8% in 2022.
  • Regeneron Pharmaceuticals' Other Non Operating Income stood at -$122.2 million in 2021, then skyrocketed by 259.82% to $195.3 million in 2022, then decreased by 1.18% to $193.0 million in 2023, then plummeted by 111.19% to -$21.6 million in 2024, then skyrocketed by 914.81% to $176.0 million in 2025.
  • The last three reported values for Other Non Operating Income were $176.0 million (Q4 2025), $755.8 million (Q3 2025), and $442.8 million (Q2 2025) per Business Quant data.